Name
osaühing Akos Apteek
Registry code
10284168
VAT number
EE100659267
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
13.10.1997 (27)
Financial year
01.01-31.12
Capital
25.00 €
Activity
47731 - Dispensing chemist in specialised stores
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tea Siimon 20.05.1960 (64) | 100% - 25.00 EUR | Board member | Direct ownership |
| 2019 02.11.2020 | 2020 29.06.2021 | 2021 30.06.2022 | 2022 30.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 364 903 € | 380 770 € | 295 983 € | 301 596 € |
| Net profit (loss) for the period | 2 034 € | 622 € | -4 493 € | 1 939 € |
| Profit Margin | 1% | 0% | -2% | 1% |
| Current Assets | 68 775 € | 62 256 € | 49 912 € | 54 592 € |
| Fixed Assets | 0 € | 8 500 € | 0 € | 0 € |
| Total Assets | 68 775 € | 70 756 € | 49 912 € | 54 592 € |
| Current Liabilities | 44 719 € | 42 078 € | 28 927 € | 37 668 € |
| Non Current Liabilities | 13 200 € | 17 200 € | 14 000 € | 8 000 € |
| Total Liabilities | 57 919 € | 59 278 € | 42 927 € | 45 668 € |
| Share Capital | - | - | - | - |
| Equity | 10 856 € | 11 478 € | 6 985 € | 8 924 € |
| Employees | 3 | 3 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 92 067.77 € | 4 019.29 € | 2 923.1 € | 2 |
| 2023 Q4 | 84 538.37 € | 3 444.29 € | 2 796.72 € | 2 |
| 2023 Q3 | 85 059.13 € | 3 424.37 € | 2 769.18 € | 2 |
| 2023 Q2 | 94 962.52 € | 4 013.44 € | 2 769.18 € | 2 |
| 2023 Q1 | 97 548.21 € | 3 787.67 € | 2 763.72 € | 2 |
| 2022 Q4 | 86 132.79 € | 2 988.77 € | 2 752.8 € | 2 |
| 2022 Q3 | 78 776.04 € | 3 258.32 € | 2 752.8 € | 2 |
| 2022 Q2 | 64 322.91 € | 3 036.93 € | 2 752.8 € | 2 |
| 2022 Q1 | 62 807.2 € | 3 258.37 € | 2 724.65 € | 2 |
| 2021 Q4 | 65 594.12 € | 2 881.43 € | 2 618.7 € | 2 |
| 2021 Q3 | 72 421.49 € | 3 280.9 € | 2 664.78 € | 2 |
| 2021 Q2 | 89 246.16 € | 3 155.3 € | 2 664.78 € | 2 |
| 2021 Q1 | 83 343.93 € | 4 347.22 € | 3 241.32 € | 4 |
| 2020 Q4 | 94 090.36 € | 3 932.12 € | 3 031.38 € | 4 |
| 2020 Q3 | 95 404.31 € | 3 912.01 € | 3 031.38 € | 4 |
| 2020 Q2 | 100 504.01 € | 4 221.53 € | 3 031.38 € | 4 |
| 2020 Q1 | 92 488.04 € | 4 000.18 € | 2 913.55 € | 4 |
